In the 9-month-old APP/PS1 mouse, VB reduced anxiety, improved memory and spatial cognition, suppressed the deposition of Aβ and tau protein phosphorylation, and decreased the overexpression of 4-HNE and MANF in the hippocampus. The gene discussed is APP; the disease is Anxiety.